XBiotech (XBIT) EV to EBIT (2015 - 2026)
XBiotech (XBIT) posted EV to EBIT of 6.41 for Q2 2026, up 262.11% on a QoQ basis from 1.77 in Q4 2025, and down 34.89% year-over-year from 9.85 in Q2 2025.
Powered by 
Analysis
XBiotech (XBIT) EV to EBIT (2015 - 2026) Analysis & Trends
XBiotech has reported EV to EBIT for 12 years, with the latest figure at 6.41 in Q2 2026.
- On a quarterly basis, EV to EBIT fell 34.89% year-over-year to 6.41 in Q2 2026; TTM through Jun 2026 was 0.82, a 52.2% decrease from a year earlier, with the FY2025 full-year figure at 0.95, down 23.1% from the prior year.
- EV to EBIT was 6.41 for Q2 2026 at XBiotech, up from 1.77 in the prior quarter.
- The five-year high for EV to EBIT was 17.21 in Q3 2022, with the low at 6.64 in Q3 2024.
- Average EV to EBIT over 5 years is 5.69, with a median of 5.97 recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: EV to EBIT surged 479.19% in 2023, then plunged 173.67% in 2024.
- Over 5 years, EV to EBIT stood at 13.56 in 2022, then slumped by 32.76% to 9.11 in 2023, then plunged by 34.47% to 5.97 in 2024, then slumped by 70.36% to 1.77 in 2025, then soared by 262.11% to 6.41 in 2026.
- The last three EV to EBIT figures came in at 6.41 (Q2 2026), 1.77 (Q4 2025), and 10.96 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | XBiotech | 66.16 Mn | 66.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.41 |
| Dec 31, 2025 | 1.77 |
| Sep 30, 2025 | 10.96 |
| Jun 30, 2025 | 9.85 |
| Mar 31, 2025 | 4.22 |
| Dec 31, 2024 | 5.97 |
| Sep 30, 2024 | -6.64 |
| Jun 30, 2024 | 2.13 |
| Mar 31, 2024 | -4.29 |
| Dec 31, 2023 | 9.11 |
| Sep 30, 2023 | 9.01 |
| Jun 30, 2023 | 1.81 |
| Mar 31, 2023 | 15.07 |
| Dec 31, 2022 | 13.56 |
| Sep 30, 2022 | 17.21 |
| Jun 30, 2022 | 4.50 |
| Mar 31, 2022 | -3.97 |
| Dec 31, 2021 | -14.15 |
| Sep 30, 2021 | -41.48 |
| Jun 30, 2021 | -17.15 |